The finding that DERL3 hypermethylation occurs across a wide spectrum of tumour types is also a likely cause of the observed high level of expression of SLC2A1 in human primary tumours that is correlated with invasiveness and metastatic potential26. The gene discussed is DERL3; the disease is neoplasm.